Cargando…
Biomarker Changes and Molecular Signatures Associated with Takayasu Arteritis Following Treatment with Glucocorticoids and Tofacitinib
OBJECTIVE: This study aimed to analyze biomarker changes in patients with TAK following treatment with glucocorticoids (GCs) and tofacitinib (TOF). METHODS: Seventeen patients from a prospective TAK cohort treated with GCs and TOF and 12 healthy individuals were recruited. TAK associated cytokines,...
Autores principales: | Dai, Xiaojuan, Wang, Jinghua, Zhang, Xiao, Wang, Li, Wu, Sifan, Chen, Huiyong, Sun, Ying, Ma, Lili, Ma, Lingying, Kong, Xiufang, Jiang, Lindi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357419/ https://www.ncbi.nlm.nih.gov/pubmed/35945989 http://dx.doi.org/10.2147/JIR.S369963 |
Ejemplares similares
-
A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis
por: Kong, Xiufang, et al.
Publicado: (2022) -
COVID-19 vaccine uptake, hesitancy and clinical effects on patients with Takayasu’s arteritis: A web-based questionnaire survey from a large cohort
por: Kong, Xiufang, et al.
Publicado: (2023) -
Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis
por: Kong, Xiufang, et al.
Publicado: (2021) -
Serum leptin, a potential predictor of long‐term angiographic progression in Takayasu’s arteritis
por: Ma, Lili, et al.
Publicado: (2019) -
Risk factors of aortic regurgitation progression in Chinese patients
with Takayasu’s arteritis: a prospective cohort study
por: Wang, Yujiao, et al.
Publicado: (2022)